Literature DB >> 7758210

Differentiation between organophosphate and carbamate poisoning.

M Rotenberg1, M Shefi, S Dany, I Dore, M Tirosh, S Almog.   

Abstract

We propose a novel and simple assay for the real-time differentiation between carbamate and organophosphate inhibition of cholinesterase, based on our observations of the kinetic behavior of inhibited enzyme. The assay of carbamylated cholinesterase activity over time follows a non-linear kinetic pattern, whereas that of phosphorylated enzyme activity is linear. This feature can be exploited to differentiate between carbamate and organophosphate cholinesterase inhibition. The non-linear pattern characteristic of carbamates is easily discernible at degrees of inhibition of 40% or more. In this setting, cholinesterase activity ought to be measured continuously for about 1 h to obtain the kinetic pattern of enzyme activity. The initial activity, measured during the first 5 min of assay, represents the activity of enzyme in vivo. In vitro reactivation of inhibited cholinesterase allows the estimation of full potential activity of enzyme prior to poisoning, so that percentage of inhibition can be calculated. Reactivation of carbamylated cholinesterase is obtained by the incubation of diluted enzyme at 37 degrees C for 2.5 h prior to assay, whereas phosphorylated (non-aged) enzyme is reactivated by a 30 min incubation with oximes. In cases of mild exposure to cholinesterase inhibitors (< 40% inhibition), the response of enzyme to in vitro reactivation serves as a complementary test for exposure and for the nature of the inhibitor. All the results presented in this work refer to plasma cholinesterase. Erythrocyte cholinesterase was found to behave very similarly to plasma enzyme and its results have not been reported here.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758210     DOI: 10.1016/0009-8981(94)05969-y

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Efficacy of Recommended Prehospital Human Equivalent Doses of Atropine and Pralidoxime Against the Toxic Effects of Carbamate Poisoning in the Hartley Guinea Pig.

Authors:  Matthew K Brittain; Kevin G McGarry; Robert A Moyer; Michael C Babin; David A Jett; Gennady E Platoff; David T Yeung
Journal:  Int J Toxicol       Date:  2016-04-21       Impact factor: 2.032

2.  Fetal exposure to propoxur and abnormal child neurodevelopment at 2 years of age.

Authors:  Enrique M Ostrea; Alexis Reyes; Esterlita Villanueva-Uy; Rochelle Pacifico; Bernadette Benitez; Essie Ramos; Rommel C Bernardo; Dawn M Bielawski; Virginia Delaney-Black; Lisa Chiodo; James J Janisse; Joel W Ager
Journal:  Neurotoxicology       Date:  2011-12-01       Impact factor: 4.294

3.  A Butyrylcholinesterase Camera Biosensor Tested for Carbofuran and Paraoxon Assay.

Authors:  Miroslav Pohanka; Jitka Zakova
Journal:  Int J Anal Chem       Date:  2022-04-07       Impact factor: 1.885

4.  Reactivation of plasma butyrylcholinesterase by pralidoxime chloride in patients poisoned by WHO class II toxicity organophosphorus insecticides.

Authors:  Lisa A Konickx; Franz Worek; Shaluka Jayamanne; Horst Thiermann; Nicholas A Buckley; Michael Eddleston
Journal:  Toxicol Sci       Date:  2013-09-19       Impact factor: 4.849

5.  Effect of chlorpyrifos on sperm characteristics and testicular tissue changes in adult male rats.

Authors:  Mojtaba Babazadeh; Gholamreza Najafi
Journal:  Vet Res Forum       Date:  2017-12-15       Impact factor: 1.054

6.  A Case Report of Prolonged Apnea during ECT in a Patient with Suicidal Attempt by Organophosphorus Poison.

Authors:  Sussan Moudi; Ebrahim Alijanpour; Ali-Asghar Manouchehri; Hasan Jafarian
Journal:  Iran J Psychiatry Behav Sci       Date:  2012

7.  A study of effectiveness of fresh frozen plasma in organophosphorous compound poisoning in reducing length of Intensive Care Unit stay and in reducing need for tracheostomy.

Authors:  V P Dayananda; B Bhaskara; G N P Pateel
Journal:  Anesth Essays Res       Date:  2016 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.